28+ years in pharmaceutical R&D and commercial analytical and CMC arenas covering all major therapeutic areas and dosage forms, GMP and GLP, branded, generics, and OTC. Work experience at Pfizer, AstraZeneca, GSK, Novartis, Bristol Myers Squibb, Endo. USP Council of Experts Member and Chair small molecule Therapeutic Area 4, 2025-2030.